UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 
 

Date of Report (Date of the earliest event reported)

February 12, 2015

 
 
 
ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)
 
 
 
Delaware 000-20852 16-1387013
(State of incorporation) (Commission File Number) (IRS Employer Identification No.)
 
2000 Technology Parkway, Newark, New York 14513
(Address of principal executive offices) (Zip Code)
 
(315) 332-7100
(Registrant’s telephone number, including area code)
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
       
 
 

  

Item 2.02 Results of Operations and Financial Condition

 

NEWARK, N.Y. – February 12, 2015 -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $1.0 million on revenue of $19.9 million for the quarter ended December 31, 2014. For the fourth quarter of 2013, the Company reported operating income of $0.2 million on revenue of $20.2 million.

 

“Consistent with our objectives, in 2014 we realized initial returns on the new product development investments made in power systems designed for medical devices and carts, portable power solutions, and integrated communications systems, while we expanded our global sales footprint. Battery & Energy Products contributed profitable growth with sales of commercial products increasing 32% and representing 62% of the segment’s sales mix for the year, further diversifying its non-government/defense revenue base,” said Michael D. Popielec, Ultralife’s President and Chief Executive Officer.

 

“Financially, our fourth quarter results reflect successful execution and demonstrate the operating leverage of our business model. We generated a consolidated gross margin of 31.7%, up 400 basis points over last year, and an operating income of $1.0 million. Having brought 2014 to a close on a strong note, the elements of our long-term strategic and operational plans are coalescing, and we are heading in the right direction to generate organic top-line growth and profitability in 2015,” concluded Popielec.

 

Fourth Quarter 2014 Financial Results

 

Revenue was $19.9 million, compared to $20.2 million for the fourth quarter of 2013, a $0.2 million or 1% decline reflecting an increase of $0.9 million in Battery & Energy Products sales, offset by a $1.1 million decrease in Communications Systems sales. Battery & Energy Products sales were $16.8 million, compared to $15.9 million last year, a 6% increase, with sales to commercial customers increasing 47% and Government/Defense sales decreasing 24%. Communications Systems sales were $3.2 million, compared to $4.3 million for the same period last year, a decrease of 26% reflecting ongoing soft order flow for amplifiers for U.S. Government/Defense tactical radios. On a consolidated basis, sales to commercial customers accounted for 49% of total revenue, up from 33% last year.

 

Gross profit was $6.3 million, or 31.7% of revenue, compared to $5.6 million or 27.7% of revenue for the same quarter a year ago. The 400 basis point increase primarily reflects the increased sales of higher margin commercial products, favorable mix of new products and increased production volumes leading to Lean productivity gains and overhead leverage. Battery & Energy Products gross margin was 30.0%, 390 basis points higher than the 26.1% reported last year, and Communications Systems gross margin was 40.6%, a 710 basis point improvement from the 33.5% reported last year.

 

Operating expenses were $5.3 million compared to $5.4 million last year reflecting ongoing discretionary spending discipline while investing in new product development. Operating expenses were 26.5% of revenue, compared to 26.6% for the year earlier period.

 

As a result of the increase in gross profit and lower operating expenses, the Company reported operating income of $1.0 million compared to $0.2 million last year and a 410 basis point improvement in the operating margin to 5.2% from 1.1% last year. Adjusted EBITDA, defined as EBITDA including non-cash, stock based compensation, was $2.1 million, or 10.4% of revenue, compared to $1.4 million, or 6.9% of revenue for the same quarter a year ago. And, net income was $0.9 million, or $0.05 per share, compared to $0.1 million, or $0.01 per share for the fourth quarter of 2013.

 

During the fourth quarter, Ultralife repurchased 56,197 shares under its 1.8 million share repurchase program.

 

Management cautions that the timing of orders and shipments may cause variability in quarterly results. 

 

The information set forth in this Form 8-K and the attached exhibit is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed to be incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing. 

 
 

 

Item 9.01 Financial Statements, Pro Forma Financials and Exhibits.

(a) Exhibits

99.1 Press Release of Ultralife Corporation dated February 12, 2015

 
 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 12, 2015   ULTRALIFE Corporation
     
     
  By: /s/ Philip A. Fain
    Philip A. Fain
    Chief Financial Officer and Treasurer
     

 

 

 

 

EXHIBIT INDEX

 

 

Exhibit No.                                   Description

 

    99.1            Press Release of Ultralife Corporation dated February 12, 2015

 

Exhibit 99.1

 

Company Contact: Investor Relations Contact:
Ultralife Corporation LHA
Philip A. Fain Jody Burfening
(315) 210-6110 (212) 838-3777
pfain@ulbi.com jburfening@lhai.com

  

Ultralife Corporation Reports Fourth Quarter Results

 

NEWARK, N.Y. – February 12, 2015 -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $1.0 million on revenue of $19.9 million for the quarter ended December 31, 2014. For the fourth quarter of 2013, the Company reported operating income of $0.2 million on revenue of $20.2 million.

 

“Consistent with our objectives, in 2014 we realized initial returns on the new product development investments made in power systems designed for medical devices and carts, portable power solutions, and integrated communications systems, while we expanded our global sales footprint. Battery & Energy Products contributed profitable growth with sales of commercial products increasing 32% and representing 62% of the segment’s sales mix for the year, further diversifying its non-government/defense revenue base,” said Michael D. Popielec, Ultralife’s President and Chief Executive Officer.

 

“Financially, our fourth quarter results reflect successful execution and demonstrate the operating leverage of our business model. We generated a consolidated gross margin of 31.7%, up 400 basis points over last year, and an operating income of $1.0 million. Having brought 2014 to a close on a strong note, the elements of our long-term strategic and operational plans are coalescing, and we are heading in the right direction to generate organic top-line growth and profitability in 2015,” concluded Popielec.

 

Fourth Quarter 2014 Financial Results

 

Revenue was $19.9 million, compared to $20.2 million for the fourth quarter of 2013, a $0.2 million or 1% decline reflecting an increase of $0.9 million in Battery & Energy Products sales, offset by a $1.1 million decrease in Communications Systems sales. Battery & Energy Products sales were $16.8 million, compared to $15.9 million last year, a 6% increase, with sales to commercial customers increasing 47% and Government/Defense sales decreasing 24%. Communications Systems sales were $3.2 million, compared to $4.3 million for the same period last year, a decrease of 26% reflecting ongoing soft order flow for amplifiers for U.S. Government/Defense tactical radios. On a consolidated basis, sales to commercial customers accounted for 49% of total revenue, up from 33% last year.

 

Gross profit was $6.3 million, or 31.7% of revenue, compared to $5.6 million or 27.7% of revenue for the same quarter a year ago. The 400 basis point increase primarily reflects the increased sales of higher margin commercial products, favorable mix of new products and increased production volumes leading to Lean productivity gains and overhead leverage. Battery & Energy Products gross margin was 30.0%, 390 basis points higher than the 26.1% reported last year, and Communications Systems gross margin was 40.6%, a 710 basis point improvement from the 33.5% reported last year.

 

 
 

Operating expenses were $5.3 million compared to $5.4 million last year reflecting ongoing discretionary spending discipline while investing in new product development. Operating expenses were 26.5% of revenue, compared to 26.6% for the year earlier period.

 

As a result of the increase in gross profit and lower operating expenses, the Company reported operating income of $1.0 million compared to $0.2 million last year and a 410 basis point improvement in the operating margin to 5.2% from 1.1% last year. Adjusted EBITDA, defined as EBITDA including non-cash, stock based compensation, was $2.1 million, or 10.4% of revenue, compared to $1.4 million, or 6.9% of revenue for the same quarter a year ago. And, net income was $0.9 million, or $0.05 per share, compared to $0.1 million, or $0.01 per share for the fourth quarter of 2013.

 

During the fourth quarter, Ultralife repurchased 56,197 shares under its 1.8 million share repurchase program.

 

About Ultralife Corporation

 

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

 

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorp.com.

 

 

Conference Call Information

 

Ultralife will hold its fourth quarter earnings conference call today at 10:00 AM ET. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A live webcast of the conference call will be available to investors in the Events & Presentations section of the Company's website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: potential reductions in U.S. military spending, uncertain global economic conditions and acceptance of our new products on a global basis. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

 
 

ULTRALIFE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands)
(unaudited)
       
ASSETS
   December 31,
   2014  2013
Current assets:          
    Cash and cash equivalents  $17,866   $16,489 
    Trade accounts receivable, net   11,295    14,238 
    Inventories, net   26,086    26,053 
    Prepaid expenses and other current assets   1,583    1,878 
          Total current assets   56,830    58,658 
Property, equipment and improvements, net   9,812    10,202 
Goodwill, intangibles and other assets   20,980    21,334 
          Total assets  $87,622   $90,194 
           
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:          
    Accounts payable  $6,996   $7,053 
    Accrued compensation and related benefits   1,725    1,908 
    Accrued expenses and other current liabilities   2,470    3,214 
           Total current liabilities   11,191    12,175 
Deferred income taxes and other non-current liabilities   4,518    4,374 
           Total liabilities   15,709    16,549 
           
Commitments and contingencies           
           
Shareholders' equity:          
    Common stock   1,895    1,888 
    Capital in excess of par value   175,939    174,932 
    Accumulated deficit   (96,920)   (94,804)
    Accumulated other comprehensive loss   (467)   (614)
    Treasury stock   (8,420)   (7,658)
          Total Ultralife equity   72,027    73,744 
Noncontrolling interest   (114)   (99)
          Total shareholders’ equity   71,913    73,645 
           
          Total liabilities and shareholders' equity  $87,622   $90,194 
 
 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In Thousands except per share amounts)
(unaudited)
       
  Three month periods ended  Year ended
   December 31,  December 31,
   2014  2013  2014  2013
Revenues:                    
   Battery & energy products  $16,772   $15,861   $56,772   $57,077 
   Communication systems   3,176    4,315    9,722    21,758 
      Total revenues   19,948    20,176    66,494    78,835 
                     
Cost of products sold:                    
   Battery & energy products   11,745    11,714    41,256    42,739 
   Communication systems   1,886    2,869    5,888    13,475 
      Total cost of products sold   13,631    14,583    47,144    56,214 
                     
     Gross profit   6,317    5,593    19,350    22,621 
                     
Operating expenses:                    
  Research and development   1,323    1,403    5,333    5,859 
  Selling, general and administrative   3,962    3,967    15,460    17,386 
     Total operating expenses   5,285    5,370    20,793    23,245 
                     
Operating income (loss)   1,032    223    (1,443)   (624)
                     
Other (expense) income:                    
  Interest income   1    12    13    39 
  Interest and financing expense   (65)   (39)   (218)   (238)
  Miscellaneous   (26)   5    (154)   (26)
Income (loss) from continuing operations before income taxes   942    201    (1,802)   (849)
Income tax provision   91    104    268    239 
                     
Net income (loss) from continuing operations   851    97    (2,070)   (1,088)
Income (loss) from discontinued operations, net of tax   —      (31)   (61)   128 
                     
Net income (loss)   851    66    (2,131)   (960)
Net loss attributable to non-controlling interest   2    3    15    34 
                     
Net income (loss) attributable to Ultralife   853    69    (2,116)   (926)
Other comprehensive income:                    
     Foreign currency translation adjustments   (17)   (47)   147    6 
                     
Comprehensive income (loss) attributable to Ultralife  $836   $22   $(1,969)  $(920)
                     
Net income (loss) per share attributable to Ultralife common shareholders – basic:                    
       Continuing operations  $.05   $.01   $(.12)  $(.06)
       Discontinued operations   .00    .00    (.00)   .01 
          Total  $.05   $.00   $(.12)  $(.05)
Net income per share attributable to Ultralife common shareholders – diluted:                    
       Continuing operations  $.05   $.01           
       Discontinued operations   .00    .00           
          Total  $.05   $.00           
                     
Weighted average shares outstanding – basic   17,374    17,477    17,475    17,465 
Weighted average shares outstanding – diluted   17,513    17,572